Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
ZEVRA THERAPEUTICS, INC.Zevra Therapeutics Reports 487% Revenue Increase to $25.9 Million in Q2 2025
Decoy Therapeutics Inc.Salarius Pharmaceuticals Reports Decreased Losses and Pursues Merger with Decoy Therapeutics
Netcapital Inc.Netcapital Inc. Reports 82.4% Revenue Decline for Fiscal Year Ending April 30, 2025
Mineralys Therapeutics, Inc.Mineralys Therapeutics Reports $43.3 Million Net Loss in Q2 2025
Knightscope, Inc.Knightscope Reports 14% Revenue Decline in Q2 2025, Increases R&D Spending
NeuroPace IncNeuroPace Reports 22% Revenue Growth to $23.5 Million in Q2 2025
ClearPoint Neuro, Inc.ClearPoint Neuro Reports 17% Revenue Growth in Q2 2025, Faces Increased Net Loss
Beyond Air, Inc.Beyond Air Reports Revenue Growth to $1.76 Million and Improved Net Loss in Latest 10-Q Filing
RAPID MICRO BIOSYSTEMS, INC.Rapid Micro Biosystems Reports 9.7% Revenue Growth in Q2 2025, Net Loss Improves
CORNER GROWTH ACQUISITION CORP. 2Corner Growth Acquisition Corp. 2 Reports Q2 2025 Net Loss of $64,922 Amid Financial Challenges
Corner Growth Acquisition Corp.Corner Growth Acquisition Corp. Reports Net Income of $11,807 in Q2 2025
SIEBERT FINANCIAL CORPSiebert Financial Corp. Reports Revenue Decline and Operating Loss in Q2 2025
INTRUSION INCIntrusion Inc. Reports 28% Revenue Growth to $1.9 Million in Q2 2025
UNITED STATES ANTIMONY CORPUnited States Antimony Corporation Reports 187% Revenue Growth to $10.5 Million in Q2 2025
Acumen Pharmaceuticals, Inc.Acumen Pharmaceuticals Reports $40.9 Million Net Loss in Q2 2025, Driven by Increased R&D Expenses
MANNATECH INCMannatech Reports Decline in Sales and Increased Net Loss for Q2 2025
M-tron Industries, Inc.M-tron Industries Reports 12.5% Revenue Growth in Q2 2025, Net Income Declines
Terrestrial Energy Inc. /DE/HCM II Acquisition Corp. Reports Net Income of $601,027 for Quarter Ending June 30, 2025
NETLIST INCNetlist Reports 13% Revenue Growth in Q2 2025, Net Loss Narrows
NEXGEL, INC.NexGel Reports 100.3% Revenue Growth to $2.884 Million in Latest Quarter
Syra Health CorpSyra Health Corp. Reports Q2 2025 Financial Results with $1.95M in Revenue
Xenetic Biosciences, Inc.Xenetic Biosciences Reports Decrease in Revenue and Continued Net Loss for Q2 2025
Southland Holdings, Inc.Southland Holdings Reports 14.4% Revenue Decline in Q2 2025, Net Loss Narrows
CO2 Energy Transition Corp.CO2 Energy Transition Corp. Reports Net Income of $418,891 for Quarter Ending June 30, 2025
Caris Life Sciences, Inc.Caris Life Sciences Reports 81.3% Revenue Growth to $181.4 Million in Q2 2025